Edit

EcoR1 Capital

https://www.ecor1cap.com
Last activity: 10.02.2024
Invests in categories: DevelopmentBioTechDrugHealthTechPlatformMedtechProductTechnologyManufacturingLife
We are a San Francisco based biotech-focused investment fund. Come forge the future of biotech with us.
Portfolio
67
Persons
18
Mentions
3

Portfolio 67

DateNameWebsiteTotal RaisedLocation
08.11.2023MorphImmun...morphimmun...$17.1MUnited Sta...
08.11.2023Therapeuti...paratussci...-United Sta...
08.11.2023Terremoto ...terremotob...$175M-
25.06.2023Epikastepikast.co...-United Sta...
-ArtivaBioartivabio....$198MUnited Sta...
-Denali The...denalither...$347MUnited Sta...
-Eikon Ther...eikontx.co...$666MUnited Sta...
-Atreca, In...atreca.com$222MUnited Sta...
-KindredBiokindredbio...$50MUnited Sta...
-elevatebioelevate.bi...$1.1BUnited Sta...
Show more

Persons 18

DateFirst NameLast NameTitleLinkedInLocation
-AlexTkachenkoExecutive ...linkedin.c...-
-SarahSpencerPRINCIPALlinkedin.c...-
-BradProsekOperating ...linkedin.c...-
-ScottPerlenCFOlinkedin.c...-
-CatherineMcWilliamsDirector o...linkedin.c...-
-MirandaFornaroOperations...linkedin.c...-
-BasheerZadaPRINCIPALlinkedin.c...-
-KristinFabianskiChief of S...linkedin.c...-
-MaddieGehrichInvestor R...linkedin.c...-
-CarolineStoutPartnerlinkedin.c...-
Show more

Mentions in press and media 3

DateTitleDescriptionSource
28.10.2020Ally Bridge Portfolio News – Nuvation Bio and Panacea Announ...NEW YORK – – October 21, 2020 – Nuvation Bio, Inc., a biopharmaceutical company focused on revolutio...ally-bridg...
10.08.2015Daily funding roundup - August 10, 2015Editas Medicine Inc secured $120M; Turing Pharmaceuticals bagged $90M; Vainglory raised $26M Editas ...vator.tv/n...
10.08.2015Genome editing company Editas gets infused with $120MInvestors in the company include Google Ventures, Khosla Ventures and Bill Gates We like to complain...vator.tv/n...

Reviews 0

Sign up to leave a review

Sign up Log In